BACTERIAL DNA GYRASE IS NOT THE TARGET OF QUINOLINE-BASED ANTI-TUBERCULOSIS COMPOUNDS  

Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2013, Vol 4, Issue 1

Abstract

Few quinoline-based synthetic compounds (2, 8 Dicyclopentyl-4-methyl quinoline and 2, 8 Dicyclohexyl-4-methyl quinoline), the synthesis of which have been already shown by our medicinal chemistry group, were found to be potent inhibitor of mycobacterial growth. Based on the results of cell culture-based cell killing assays using DNA gyrase positive E. coli strains, we presumed that bacterial DNA gyrase might be a probable target of quinolines. The resemblance of the basic skeletal structural moiety of quinolone and quinoline inspired us to hypothesize that these quinolines might inhibit DNA gyrase. While the non-gyrase inhibitors like ethambutol and isoniazid did not inhibit the growth of these strains. The genesis of the notion of using E. coli DNA gyrase as an alternative to DNA gyrase from the pathogenic Mycobacterium, stems from the fact that E. coli DNA gyrase is found to be about eighty times more sensitive to the action of quinolones than the Mycobacterium DNA gyrase. Therefore, we had used E. coli DNA gyrase as a model enzyme for studying the action of some synthetic quinoline compounds synthesized by us. In the present work, we have used cell killing assay, gel electrophoresis assay (for DNA supercoiling) and UV spectroscopy-based coupled assay (for ATP hydrolysis) for characterizing the activity of DNA gyrase. Quinolones exhibited low IC50 values as compared to the studied quinolines on DNA gyrase positive E. coli strains We found that although quinolones are the potent inhibitors of supercoiling activity of E. coli DNA gyrase, quinolines are not. We further found that ATPase activity of E. coli DNA gyrase (Non-specific inhibitor) was inhibited to a very minor extent in the presence of very high concentration of these synthetic quinolines. DNA gyrase is not the primary target of these synthetic quinolines (2, 8 Dicyclopentyl-4-methyl quinoline and 2, 8 Dicyclohexyl-4-methyl quinoline). 

Authors and Affiliations

Rahul Verma , Rajan Tripathy , Manash Paul , Amit Nayyar , Anup Mukhopadhyay

Keywords

Related Articles

IMPORTANCE OF NANOROBOTS IN HEALTH CARE 

A nanorobot is a tiny machine designed to perform a specific tasks repeatedly and with precision at nanoscale dimensions. Nanorobotics will have a diameter of about 0.5 to 3 microns and will be constructed out of parts w...

FORMULATION AND EVALUATION OF SUSTAINED RELEASE PELLETS OF TRAMADOL HYDROCHLORIDE  

The aim of the present research is to develop and evaluate a better sustained release multiple unit pellets (MUP) formulation of Tramadol hydrochloride. Dissolution and diffusion controlled systems have classically been...

WOUND HEALING ACTIVITY ON THE LEAVES OF ACHILLEA MILLEFOLIUM L. BY EXCISION, INCISION, AND DEAD SPACE MODEL ON ADULT WISTAR ALBINO RATS 

The aim of present study was to investigate the wound healing activity of the Indian medicinal plant Achillea millefolium L. The alcoholic and aqueous extracts of leaves of Achillea millefolium L was studied for its effe...

DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING RP-HPLC METHOD FOR DETERMINATION OF ESLICARBAZEPINE IN ESLICARBAZEPINE ACETATE TABLETS 

A simple, precise, rapid and accurate stability indicating reverse phase high performance liquid chromatography has been developed and validated for the estimation of Eslicarbazepine Acetate in tablet dosage form. Separa...

USE OF POROUS CARRIERS IN THE DEVELOPMENT OF INTRAGASTRIC FLOATING DRUG DELIVERY SYSTEMS: REVIEW 

Considerable research efforts have been used in the development of floating drug delivery system including gas generation system, swelling systems and low density systems. In the development of low density systems the po...

Download PDF file
  • EP ID EP151241
  • DOI -
  • Views 63
  • Downloads 0

How To Cite

Rahul Verma, Rajan Tripathy, Manash Paul, Amit Nayyar, Anup Mukhopadhyay (2013). BACTERIAL DNA GYRASE IS NOT THE TARGET OF QUINOLINE-BASED ANTI-TUBERCULOSIS COMPOUNDS  . International Research Journal of Pharmacy (IRJP), 4(1), 284-292. https://europub.co.uk/articles/-A-151241